Macrogenics MGNX
NASDAQ MGNX
$3.49 +0.16 (+4.80%)
At close: Oct 20, 2026 · 4:00 PM EDT

Macrogenics (MGNX) Receivables - Other (2014 - 2026)

Updated

Macrogenics (MGNX) reported Receivables - Other of $119.58 million for Q2 2026.

Analysis

Macrogenics (MGNX) Receivables - Other (2014 - 2026) Analysis & Trends

At the end of FY2014, Macrogenics posted Receivables - Other of $500,000.

  • The Q2 2026 figure ranks as the lowest quarterly Receivables - Other since Q3 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Macrogenics 223.85 Mn -93.92 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 119.58 Mn
Sep 30, 2015 900,000.00
Jun 30, 2015 800,000.00
Mar 31, 2015 0.60
Dec 31, 2014 500,000.00
Sep 30, 2014 412,500.00
API Access

Macrogenics Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=MGNX&period=max&api_key=YOUR_API_KEY